Similar Posts
Patient vs. Portfolio: ImClone – Salon
Patient vs. Portfolio: ImClone_Salon December 9, 2002 Salon.com looks at how conflicts of interest impact on patients who are recruited to serve as subjects of clinical drug trials. “Patients affected by the ImClone scandal have been lost in the media’s rush to cover the tale of Martha Stewart and other…
Rutherford Institute Interview: Allen Jones reveals TMAP drug scam linked to then Governor George W. Bush
Rutherford Institute Interview: Allen Jones reveals TMAP drug scam linked to then Governor George W. Bush Fri, 14 Oct 2005 An in-depth interview by John Whitehead of the Rutherford Institute with Allen Jones,*a former inspector with the Pennsyvania Office of Inspector General, who initially blew the whistle on Pennsylvania’s version…
Recycled drugs: failed antidepressants– Stratera marketed for ADHD; Cymbalta for incontinence
Recycled drugs: failed antidepressants– Stratera marketed for ADHD; Cymbalta for incontinence Mon, 26 Apr 2004 A front page article in The Wall Street Journal (excerpt below) provides a roadmap of failed Eli Lilly drugs which the company repackaged for a different condition than the one for which the drugs had…
FDA: Regulatory Protections for Children
Comments submitted by Vera Hassner Sharav, John H. Noble, Jr., Ph.D and Howard Fishman, MEd, MSW for AHRP
To: Dr. Bernard Schwetz Acting Commissioner Food and Drug Administration, Dockets Management Branch (HFA-305) Food and Drug Administration
Re: COMMENT ON: Docket #00N-0074 April 24, 2001 Interim Rule: "Additional Safeguards for Children in Clinical Investigations of FDA-Regulated Products
Excerpt: The FDA rightly chose not to permit the section 46.408 (c) waiver by IRBs of parental or guardian permission, as it leaves the specific circumstances for such a violation of parental rights to the discretion of local Institutional Review Boards (IRB). Given the stream of revelations of gross ethical and procedural violations at one after another of the nation’s premier research institutions, assumptions that “procedural safeguards are in place,” or that IRBs can be relied upon to make decisions that protect the best interests of human subjects – adults and children – has been debunked.
Boston Globe series by Alice Dembner documents harm to children in clinical trials
Feb-March, 2001. Boston Globe series by Alice Dembner documents harm to children in clinical trials DANGEROUS DOSAGE Published on February 18, 2001. Author(s): Alice Dembner, Globe Staff TESTING CHILDREN’S DRUGS Published on March 18, 2001. TEDDY BEARS AND VEILED THREATS Published on March 20, 2001. Author(s): Alice Dembner, Globe Staff…
Did Zoloft make him do it? FDA Zoloft data
Did Zoloft make him do it? FDA Zoloft data Tue, 8 Feb 2005 At issue beyond a Charlsteon, SC court, is whether Christopher Pittman – who was 12 years old and under the influence of Zoloft, a powerful psychotropic drug, when he killed his grandparents–should have been charged with murder…